• 3-Bromopyruvate and Cetuximab Overcome CRC Resistance via Fe

  2026-07-13

  This study demonstrates that combining 3-bromopyruvate with cetuximab overcomes resistance in colorectal cancer cells by activating autophagy-dependent ferroptosis and apoptosis. The findings provide mechanistic insight into FOXO3a pathway regulation and suggest a potential strategy for treating drug-resistant metastatic colorectal cancer.

• Phosphotungstic Acid Negative Stain: Bridging Glycan Imaging

  2026-07-13

  This article explores how 2% Phosphotungstic Acid Negative Stain Solution propels electron microscopy from a visual tool to a strategic driver in translational virology. By enabling high-contrast imaging of conserved viral glycans—such as those targeted by Concanavalin A—the reagent becomes foundational for researchers unraveling pan-coronavirus vulnerabilities and informing next-generation antiviral design.

• Angiotensin II (Asp-Arg-Val-Tyr-Ile-His-Pro-Phe): Technical

  2026-07-12

  Angiotensin II (SKU A1042) enables precise modeling of hypertension, vascular smooth muscle cell hypertrophy, and cardiovascular remodeling in preclinical research. It is not intended for diagnostic or therapeutic applications. This article distills actionable parameters and workflow guidance for cell-based and in vivo experimental setups.

• 1,2-Dioleoyl-3-trimethylammonium-propane Chloride in Precisi

  2026-07-10

  1,2-Dioleoyl-3-trimethylammonium-propane chloride (DOTAP) streamlines gene delivery with robust efficiency in both transient and stable expression workflows. Explore protocol refinements, troubleshooting insights, and how recent nanotechnology advances unlock new immunometabolic assay horizons.

• MG-132 (Z-LLL-al): Precision Proteasome Inhibition in Cancer

  2026-07-09

  MG-132 (Z-LLL-al) stands out as a gold-standard proteasome inhibitor for apoptosis, oxidative stress, and cell cycle arrest studies, empowering researchers with reproducible, selective control over protein degradation pathways. This guide delivers protocol-savvy workflows, troubleshooting insights, and advanced applications, synthesizing new mechanistic findings from recent autophagy research.

• THRA1/PGC-1α/SIRT3 Axis Links Oxidative Stress to Hypertensi

  2026-07-09

  This study elucidates how the THRA1/PGC-1α/SIRT3 signaling pathway regulates oxidative stress and contributes to hypertension in adult offspring of hypothyroid rats. The findings highlight a molecular mechanism linking maternal thyroid dysfunction to long-term vascular risk, offering new targets for hypertension prevention.

• 2-NBDG for Glucose Uptake Assays: Protocols, Insights & Opti

  2026-07-08

  2-NBDG, a fluorescent glucose analog, enables real-time, quantitative tracking of cellular glucose uptake across diverse disease models. This article details experimental workflows, advanced applications, and troubleshooting strategies, drawing on the latest mechanistic insights to boost assay reliability and interpretive power.

• HRP Goat Anti-Mouse IgG (H+L) Antibody: Technical Workflow G

  2026-07-08

  The HRP Goat Anti-Mouse IgG (H+L) Antibody (SKU K1221) enables sensitive detection of mouse primary antibodies in immunoassays where robust signal amplification is required. It is best suited for Western blot, ELISA, and immunohistochemical workflows that utilize mouse-derived primaries. This reagent is not intended for use with non-mouse species or detection formats incompatible with HRP substrates.

• Paroxetine Mesylate: Multi-Target Inhibitor for Oncology Res

  2026-07-07

  Paroxetine Mesylate is a selective serotonin reuptake inhibitor with documented multi-kinase and cytochrome P450 inhibitory activities. Evidence supports its repositioning as an anti-colorectal cancer agent via MET and ERBB3 inhibition. APExBIO provides Paroxetine Mesylate (SKU: C8698) for research applications requiring high-purity, well-characterized reagents.

• Epalrestat: Transforming Translational Neuroprotection Resea

  2026-07-07

  This article explores how Epalrestat, a high-purity aldose reductase inhibitor from APExBIO, is enabling a new era in translational research. Integrating recent mechanistic discoveries—such as direct KEAP1/Nrf2 pathway activation in Parkinson's disease models—this piece provides strategic guidance for researchers seeking rigorous, disease-relevant models of oxidative stress and neurodegeneration.

• Vorinostat's Impact on Protein Expression from mRNA Lipoplex

  2026-07-06

  This study investigates how the histone deacetylase inhibitor vorinostat affects protein expression after mRNA lipoplex delivery, both in cultured tumor cells and in vivo in mice. The findings clarify that vorinostat enhances translation from transfected mRNA at low doses in vitro but has minimal effect on in vivo protein expression, informing future experimental design for mRNA-based research.

• Resazurin Sodium Salt: Precision Fluorogenic Indicator for V

  2026-07-06

  Resazurin sodium salt stands out as a DMSO-soluble, high-sensitivity fluorogenic oxidation-reduction indicator for cell viability, proliferation, and cytotoxicity studies, outperforming legacy dyes in multiplexed and high-throughput applications. Its metabolic readout bridges complex cell models and real-world pathophysiology, empowering researchers to decode subtle toxicities and metabolic shifts across cancer, stem cell, and gut microbiota studies.

• Minoxidil sulphate in Vascular Biology: Protocols & Innovati

  2026-07-05

  Minoxidil sulphate, the potent potassium channel opener and active metabolite of minoxidil, is reshaping vascular biology and hair growth research with its unmatched solubility, purity, and reproducibility. This article details validated experimental workflows, protocol refinements, and troubleshooting strategies that leverage APExBIO's Minoxidil sulphate for high-impact, reliable results.

• DAMGO: Optimizing µ-Opioid Receptor Agonist Assays in Pain R

  2026-07-04

  DAMGO’s unmatched selectivity for the µ-opioid receptor enables precise dissection of opioid signaling and pain mechanisms. This guide provides actionable workflows, troubleshooting insights, and research-backed protocol parameters, helping chronic pain researchers unlock next-generation insights in analgesic tolerance and hypersensitivity.

• TRPV1+ Nerve Stimulation Drives Anti-Inflammatory Reflex Cir

  2026-07-03

  Song et al. (2025) demonstrate that targeted activation of TRPV1+ peripheral somatosensory nerves at the nape rapidly suppresses systemic inflammation by engaging somato-autonomic neural circuits. This work clarifies mechanistic links between sensory input and immune modulation, offering new directions for non-pharmacological intervention in inflammatory disease.

16324 records 1/1089 page Next 12345 下5页 Last page